MedPath

Sanofi

Sanofi logo
🇫🇷France
Ownership
Public
Employees
87.9K
Market Cap
$141.3B
Website
http://www.sanofi.com
Introduction

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Phase 2
Completed
Conditions
Non-Small Cell Lung Cancer
Interventions
First Posted Date
2006-07-25
Last Posted Date
2011-10-17
Lead Sponsor
Sanofi
Target Recruit Count
53
Registration Number
NCT00356122
Locations
🇺🇸

Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States

Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

Phase 2
Completed
Conditions
Pertussis
Meningococcal Meningitis
Tetanus
Diphtheria
Poliomyelitis
Interventions
Biological: Polysaccharide Diphtheria Toxoid Conjugate Vaccine
First Posted Date
2006-07-21
Last Posted Date
2011-08-24
Lead Sponsor
Sanofi
Target Recruit Count
882
Registration Number
NCT00355121

Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement

Phase 4
Completed
Conditions
Diabetes Mellitus Type 2
First Posted Date
2006-07-20
Last Posted Date
2010-08-31
Lead Sponsor
Sanofi
Target Recruit Count
480
Registration Number
NCT00354939

Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus

Phase 3
Completed
Conditions
Type 2 Diabetes Mellitus
First Posted Date
2006-07-19
Last Posted Date
2011-01-11
Lead Sponsor
Sanofi
Target Recruit Count
100
Registration Number
NCT00353691
Locations
🇺🇸

Sanofi-Aventis, Bridgewater, New Jersey, United States

Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women

Phase 3
Completed
Conditions
Osteoporosis, Postmenopausal
First Posted Date
2006-07-17
Last Posted Date
2009-12-15
Lead Sponsor
Sanofi
Target Recruit Count
171
Registration Number
NCT00353080
Locations
🇸🇪

Sanofi-Aventis, Stockholm, Sweden

Risedronate in Postmenopausal Women With Low Bone Density

Phase 2
Completed
Conditions
OSTEOPOROSIS, POSTMENOPAUSAL
First Posted Date
2006-07-12
Last Posted Date
2012-02-17
Lead Sponsor
Sanofi
Target Recruit Count
150
Registration Number
NCT00351091

LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus

Phase 4
Terminated
Conditions
Diabetes Mellitus, Type 2
First Posted Date
2006-07-10
Last Posted Date
2009-12-07
Lead Sponsor
Sanofi
Target Recruit Count
4
Registration Number
NCT00349986
Locations
🇭🇺

Sanofi-Aventis, Budapest, Hungary

Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions

Phase 4
Completed
Conditions
Dyslipidemia
Hypertension
First Posted Date
2006-07-10
Last Posted Date
2008-01-23
Lead Sponsor
Sanofi
Target Recruit Count
60
Registration Number
NCT00350038
Locations
🇭🇺

Sanofi-aventis, Budapest, Hungary

Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)

Phase 3
Completed
Conditions
Arthroplasty, Replacement, Hip
First Posted Date
2006-07-06
Last Posted Date
2009-03-27
Lead Sponsor
Sanofi
Target Recruit Count
156
Registration Number
NCT00349180
Locations
🇯🇵

Sanofi-Aventis, Tokyo, Japan

Lantus in Prediabetes

Phase 1
Completed
Conditions
Hyperglycemia
Diabetes Mellitus
First Posted Date
2006-07-06
Last Posted Date
2006-07-06
Lead Sponsor
Sanofi
Target Recruit Count
20
Registration Number
NCT00348972
Locations
🇺🇸

Sanofi-Aventis, Bridgewater, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath